About Synapse Biomedical
Synapse Biomedical is a company based in Cleveland (United States) founded in 2002. Synapse Biomedical has raised $1.76 million across 3 funding rounds from investors including University Hospitals, Case Western Reserve University and Ohio Third Frontier. Synapse Biomedical offers products and services including NeuRx DPS and Outcome Performance Measures. Synapse Biomedical operates in a competitive market with competitors including Belluscura, hemovent, ALung, Lungpacer and OneBreath, among others.
- Headquarter Cleveland, United States
- SectorsHealthcare
- Website synapsebiomedical.com
- Social LinkedIn X Facebook YouTube
- Legal Name Synapse Biomedical Inc.
- Total Equity Funding$1.76M (USD)
in 3 rounds
- Latest Funding Round$2.4M (USD), Debt – Venture
Dec 2013
- InvestorsUniversity Hospitals
& 5 more
Products & Services of Synapse Biomedical
Synapse Biomedical offers a comprehensive portfolio of products and services, including NeuRx DPS and Outcome Performance Measures.
Diaphragm pacing system to reduce ventilator dependence for neuromuscular patients
Devices for measuring and improving patient outcomes in clinical trials
Apps and channels of Synapse Biomedical
its YouTube channel Synapse Biomedical Inc has 182 subscribers and 15 videos.
Videos from Synapse Biomedical
The most watched videos on Synapse Biomedical's YouTube channel, Synapse Biomedical Inc (182 subscribers). Click a video to play it here.
More on Synapse Biomedical Inc.
Funding Insights of Synapse Biomedical
Synapse Biomedical has successfully raised a total of $1.76M across 3 strategic funding rounds. The most recent funding activity was a Debt – Venture round of $2.4 million completed in December 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.76M
- Total Rounds 3
- Last Round Debt – Venture — $2.4M
- First Round $1.33M
(Nov 2005)
- Investors Count 6
All 3 funding rounds of Synapse Biomedical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2013 | $2.4M | Debt – Venture | – | – | |
| Jan 2010 | $433,358 | Seed | – | – | – |
| Nov 2005 | $1.33M | Seed | – | Case Western Reserve University, University Hospitals | – |
6 investors in total: 6 institutional.
Investors in Synapse Biomedical
Synapse Biomedical has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include University Hospitals, Case Western Reserve University and Ohio Third Frontier.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare sector investments are managed through private equity strategies. | – | pa-investors.com | Palo Alto, United States | |
Venture capital funding is provided to tech startups by JumpStart Ventures. | – | jumpstart.vc | Cleveland, United States | |
- | – | thirdfrontier.com | - | |
Multiple courses and degrees are offered across diversified academic streams. | 1826 | case.edu | United States | |
Multispecialty hospital care is delivered through a chain of facilities. | 1866 | uhhospitals.org | United States | |
Research affiliations between universities and industries are facilitated by SciTech. | 1990 | stcc.org | Columbus, United States |
Investor details for Synapse Biomedical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Synapse Biomedical
9 people are tracked at Synapse Biomedical (6 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Anthony R. Ignagni | President & CEO | Leadership |
Moustapha Diop | Chief Operating Officer & Managing Director, Europe | Leadership |
Russ Moskol | Director of Operations | Leadership |
Jason Fiest | Vice President Quality And Regulatory | Leadership |
Timothy Crish | VP of Product Development | Leadership |
Mark Barbutes | Director of Quality & Regulatory Affairs | Leadership |
Assun Durá | Export Manager LATAM & Southern Europe | Team |
Thomas E. Herb | Technical Documentation Manager | Team |
Lynn Brandt-Perpoli | Corporate Field Trainer and Clinical Specialist | Team |
Complete people profiles for Synapse Biomedical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Synapse Biomedical
3 dated milestones of Synapse Biomedical across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Synapse Biomedical is founded.
- Funding First funding round of $1.3M.
- Funding Latest funding round, Debt – Venture, of $2.4M.
Competitors of Synapse Biomedical
Synapse Biomedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Belluscura, hemovent, ALung, Lungpacer and OneBreath, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| belluscura.com | 2015 | Dallas, United States | $6.38M | 21 | Provider of medical devices for laparoscopic procedures | |
| hemovent.com | 2013 | Aachen, Germany | $16.7M | 23 | Equipment for extracorporeal life support and CO2 removal is developed. | |
| alung.com | 1997 | Pittsburgh, United States | $132.56M | 27 | Extracorporeal CO2 removal systems are developed to supplement mechanical ventilation. | |
| lungpacer.com | 2009 | Vancouver, Canada | $121.38M | 62 | Neurostimulation-based pacer for diaphragm strength is developed. | |
| onebreathventilators.com | 2013 | Bengaluru, India | $3.45M | 26 | Portable mechanical ventilators for intensive care patients are developed. | |
| securisyn.com | 2011 | Denver, United States | $16.79M | – | Endotracheal tube stabilization systems for ventilated patients are developed. | |
| breethe.com | 2014 | Montreal, Canada | – | – | Meditation programs are delivered through a mobile app by Breethe. | |
| briodevice.com | 2010 | Doylestown, United States | $1.94M | – | Medical devices for emergency airway management are developed. |
Detailed competitors of Synapse Biomedical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Synapse Biomedical
The website of Synapse Biomedical (synapsebiomedical.com) receives about 2.5K visits a month.
- Monthly visits2.5K
▼ 27.2% vs previous month
Websites whose visitors overlap most with Synapse Biomedical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
harpermorrismemorialchapel.com | harpermorrismemorialchapel.com | 100% | – | #2,935,675 | – |
Latest news on Synapse Biomedical
Complete news archive for Synapse Biomedical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Synapse Biomedical
10 companies that operate in the same segment as Synapse Biomedical (Pulmonology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Portable oxygen concentrators are supplied for respiratory therapy needs. | 2001 | Goleta, California, United States | USD 51.65 M | USD 348.67 M | 766 | |
Cancer detection diagnostics assays are developed and offered. | 2005 | Boulder, Colorado, United States | USD 200.16 M | USD 88.5 M | 273 | |
Therapeutic devices for nasal breathing improvement are developed. | 2011 | Sunnyvale, California, United States | USD 176.4 M | – | 66 | |
Non-invasive breath-based diagnostics for cancer and infectious diseases are developed. | 2004 | Cambridge, Cambridgeshire, United Kingdom | USD 166.55 M | – | 202 | |
Protein biologics are developed for treating rare diseases. | 2005 | San Diego, California, United States | USD 171.52 M | USD 190 K | 59 | |
Therapeutics for rare respiratory diseases are developed by Savara Pharma. | 2008 | Austin, Texas, United States | USD 67.82 M | – | 59 | |
Developer of smart devices for treating pulmonary diseases | 1998 | Redwood City, California, United States | USD 280.91 M | USD 90.5 M | 291 | |
A norovirus vaccine is developed for infection prevention. | 2021 | Boston, Massachusetts, United States | USD 135 M | – | 14 | |
Oral small molecule drugs for chronic diseases are developed. | 2017 | San Francisco, California, United States | USD 233 M | – | 163 | |
Precision medicines for lung-related diseases are developed. | 2015 | Menlo Park, California, United States | USD 371 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Synapse Biomedical
Synapse Biomedical was founded in 2002 and raised its 1st funding round 3 years after it was founded.
Synapse Biomedical is headquartered in Cleveland, United States. It is registered at Cleveland, Ohio, United States.
Synapse Biomedical is a funded company, having raised a total of $1.76M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.33M, raised on Nov 2005.
Synapse Biomedical was founded in 2002 in Cleveland, United States, within the biomedical sector. The NeuRx Diaphragm Pacing System is produced, featuring implanted electrodes and an external pulse generator to stimulate diaphragm movement and support respiration. This technology is applied to reduce ventilator dependence in spinal cord injury and ALS patients. FDA approval has been granted as a humanitarian device for ALS treatment in the US.
Synapse Biomedical's top competitors include Belluscura, Lungpacer and hemovent.
Synapse Biomedical offers NeuRx DPS and Outcome Performance Measures.
Synapse Biomedical has 6 investors. Key investors include University Hospitals, Case Western Reserve University, Ohio Third Frontier, SciTech, and Palo Alto Investors.
Synapse Biomedical operates through Synapse Biomedical Inc..